ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery using Recombinant Human Hyaluronidase PH20 (PDF )
5 $
Format: Publisher PDF
File Size : 9.9 MB
Publication Year: 2022
By David W. Kang, Renee Tannenbaum ‘ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20’ provides readers with in-depth information on the potential benefits and challenges of subcutaneous (SC) drug delivery, the biology of hyaluronan and hyaluronidases in the SC space, and a comprehensive overview on the history of hyaluronidases and the development of recombinant human hyaluronidase PH20 (rHuPH20). Current applications of rHuPH20 as well as approved biotherapeutics utilizing HuPH20-facilitated SC drug delivery are summarized, and the underlying non-clinical and clinical development approaches are introduced as a basis for future application to biologics in various disease areas.
Product Details
ASIN : B0B57JMGDJ
Publisher : S. Karger; 1st edition (June 14, 2022)
Publication date : June 14, 2022
Language : English
Screen Reader : Supported
Page numbers source ISBN : 3318070769
Be the first to review “ENHANZE® Drug Delivery Technology: Advancing Subcutaneous Drug Delivery using Recombinant Human Hyaluronidase PH20 (PDF )”
You must be logged in to post a review.
Related Products
Reviews
There are no reviews yet.